Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » News & Analysis

News & Analysis


China biotech company and industry news and analysis...

Recent Articles

  Wuzhou Zhongheng Invests $52 Million in Israel's Oramed Pharma
  China's Desano Pharma to Make API for New HIV Drug for ViiV
  Provectus Signs LOI for Cancer Drug with Boehringer Ingelheim China
  Chronic Disease Rises Sharply in China
  Colorcon Opens Beijing Lab to Offer Drug Formulation Services
  Zhejiang Kanglaite to Start US Phase III Trial of TCM Cancer Drug
  Israel's Hadasit Bio Receives $2 Million from China Investors
  Week in Review: 3SBio Snags Global Rights to mAb for Arthritis
  PharmaEngine's Cancer Drug Granted Priority Review by the FDA
  Materialise Brings 3D Printing to Plan CV Surgery at Fuwai Hospital


Partner Events

Bio Taiwan 2015
July 22-26, 2015
Taipei, Taiwan

>> More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors